Unknown

Dataset Information

Drug-induced urinary incontinence in pediatric patients: A disproportionality analysis of the FDA Adverse Event Reporting System.


ABSTRACT: Despite the substantial impact of urinary incontinence (UI) on the physical and mental health of children, research on drug-induced pediatric UI (PUI) remains limited. This study aimed to identify drugs associated with PUI by analyzing data from the FDA Adverse Event Reporting System (FAERS). We analyzed FAERS data from Q1 2004 to Q4 2024 to identify PUI cases in children aged 5 to 17 years. Disproportionality signals were assessed using reporting odds ratios (RORs) and proportional reporting ratios (PRRs). Additionally, we conducted a subgroup analysis of enuresis and compared the risks of drug-induced UI between children and adults. Our analysis identified 1252 reports of PUI from the FAERS database. Montelukast was the most frequently reported drug (91 cases), followed by risperidone (7

SUBMITTER: Jin C 

PROVIDER: S-EPMC12826208 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature